Edward Busick
Internal Medicine · Waltham, MANPI 1467436931
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$581
- Sanofi-aventis U.S. LLC$445
- Pfizer$366
- Johnson & Johnson$264
- Novartis$238
- Lilly USA, LLC$189
- plus $2K from 20 others
Across 709 payments — averaging $377.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$190K
- Sanofi US Services Inc.$69K
- Eli Lilly$9K
What the payments were for
- Food & beverage$3,640100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 23 | $581 |
| Sanofi-aventis U.S. LLC | 22 | $445 |
| Pfizer | 20 | $366 |
| Johnson & Johnson | 11 | $264 |
| Novartis | 14 | $238 |
| Lilly USA, LLC | 10 | $189 |
| Regeneron Healthcare Solutions, Inc. | 8 | $182 |
| Amarin Pharma, Inc. | 8 | $166 |
| Boehringer Ingelheim | 7 | $145 |
| Lifescan, Inc. | 8 | $143 |
| AstraZeneca | 6 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $101 |
| Merck | 5 | $95 |
| Radius Health, Inc. | 4 | $88 |
| Esperion Therapeutics, Inc. | 4 | $84 |
| Valeritas, Inc. | 3 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Dexcom, Inc. | 2 | $35 |
| Novo Nordisk | 2 | $34 |
| Acerus Pharmaceuticals Corporation | 1 | $26 |
| GSK | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| Astellas Pharma US Inc | 1 | $15 |
| Medtronic | 1 | $15 |
How this compares
$3,640 in reported general payments places this provider in the 90th percentile of 4,983 internal medicine providers in Massachusetts.
Other internal medicine in Waltham
- Elenie BartzokisWaltham$222K
- Philip ReillyWaltham$89K
- David SchenkeinBoston$5M
- Alan GarberCambridge$4.9M
- John FallonBoston$1.8M
- Michael MendelsohnBoston$1.6M
- Sandra RichmanBrookline$1.4M
- Gaurav SingalBoston$798K
- Asit ParikhBoston$486K
- Noopur RajeBoston$481K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.